PubMed holds 732 randomized-trial papers on creatine supplementation, one of the deepest records in self-improvement. Two NIH pages describe its benefit and safety, and they do not use the same tone.
Whitepill finding
On 30 October 2026, PubMed held 732 randomized-trial papers on creatine supplementation, against none on BPC-157. NIH's Office of Dietary Supplements (April 2024) calls it one of the most thoroughly studied supplements for sports performance. These counts show depth of record, not benefit for you.
The short version
They sayCreatine is a muscle powder that works for everything.
The ODS sheet ties the benefit to short, intense, intermittent efforts and calls it of little value for endurance sports. See the receipt
They sayHundreds of trials mean it is right for you.
A trial count is depth of record. It does not say who was studied or how big any effect was for you. See the receipt
They sayIt is completely risk-free.
ODS lists weight gain from water retention, and NCCIH says there were reports it may impair liver and kidney function and that long-term effects have not been well studied. See the receipt
NIH's NCCIH calls creatine an amino acid produced by the body and a popular dietary supplement.[1] The Office of Dietary Supplements calls it one of the most thoroughly studied and widely used supplements to enhance exercise and sports performance.[2]
That is a much stronger record than a peptide with none. Where it sits against other topics is on the evidence ladder.
PubMed holds 732 papers typed as randomized controlled trials and 173 systematic reviews or meta-analyses for creatine supplementation.[3]
The tag is PubMed's own publication type.[4] Compare that with BPC-157, which has none typed as such, though a count still says nothing about who was studied or how large any effect was.
ClinicalTrials.gov lists 389 interventional studies matching creatine and supplementation.[5] A registration is a plan on file, and we have not assessed any of them.
The ODS sheet lists creatine as supporting short-term, mainly anaerobic activity, with numerous clinical trials generally showing a benefit for high-intensity, intermittent activity and potential variation in individual responses.[2] It says it is of little value for endurance sports.
It also says other forms of creatine have not been proven to be better than creatine monohydrate for muscle creatine levels, digestibility, product stability or safety. NCCIH is more guarded, saying creatine may somewhat enhance the effects of exercise on strength, muscle mass and endurance.[1]
1. What was the goal? The NIH pages tie the benefit to short, intense, repeated efforts, not endurance. 2. Which form? The ODS sheet says other forms are not proven better than creatine monohydrate. 3. Check the page's age. NIH's two pages differ. 4. Hidden ingredients are a supplement-wide problem, so who made the product matters. 5. Kidney or liver conditions: ask a clinician first.
ODS says creatine is considered safe for short-term use by healthy adults, and that long-term oral supplementation does not impair renal function in healthy athletes. It lists weight gain due to water retention among reported adverse effects, with anecdotal reports of nausea, diarrhea and muscle cramps.[2]
NCCIH, on a page updated in January 2021, says there were reports creatine may impair liver and kidney function, and that its long-term effects have not been well studied.[1] The same NCCIH page warns that dangerous hidden ingredients are an increasing problem in products promoted for bodybuilding.
The two pages are different ages and tones, which is why the safety question belongs with a clinician who knows your kidneys and your medicines.
PubMed counts are the evidence ladder's own for creatine supplementation, read 30 October 2026, and ClinicalTrials.gov interventional studies matching the stated terms, read 2 November 2026. NIH statements are quoted or closely paraphrased from the ODS fact sheet (updated 1 April 2024) and the NCCIH page (last updated January 2021), both read in full on 2 November 2026. Dosing and loading schedules that the ODS table prints are deliberately not copied.
Queries are broad and will include off-topic papers, and publication-type tags can be loose, so treat the counts as depth of record (our grading rules are on the methodology page, and every comparison lives on the ladder hub). Nothing here measures effect size or study quality, covers dosing or products, or is medical advice.
creatine[tiab] AND supplementation[tiab]creatine AND supplementation, interventional studiesPubMed held 732 papers typed as randomized controlled trials and 173 systematic reviews or meta-analyses for the evidence ladder's creatine supplementation query on 30 October 2026.
NIH's Office of Dietary Supplements says numerous clinical trials generally show a benefit for high-intensity, intermittent activity, with variation in individual responses, and that it is of little value for endurance sports.
ODS says it is considered safe for short-term use by healthy adults. NCCIH, on an older page, says there were reports it may impair liver and kidney function and that long-term effects have not been well studied. A clinician can weigh that for you.
No. It means the record is deep. Effect size, study quality and your own situation are separate questions for a clinician.
Creatine has one of the deepest trial records in the scene, and NIH ties its benefit to short, intense efforts while describing safety in two different tones. Use the count to see that the record exists, then ask a clinician about you.